Company intelligence / Profile preview

Yunyi Pharmaceutical

Beijing, Beijing, China

Ownership: Private
Employees: ~150
Development stage: Other

Overview

Yunyi Pharmaceutical is a China-based biotechnology company specializing in precision medicine and the development of innovative oncology therapeutics. The company integrates advanced molecular diagnostics with drug discovery to provide personalized treatment solutions, particularly for non-small cell lung cancer and other solid tumors. Yunyi focuses on identifying specific genetic biomarkers to guide the development of targeted small molecule inhibitors and companion diagnostic kits. By bridging the gap between diagnostics and therapy, the company aims to improve clinical outcomes and optimize patient selection for targeted treatments.

Therapeutic areas: Oncology
Modalities: Small moleculeDiagnostic test
Industry: Biotech

Partnerships

Various Chinese hospitals and oncology research centers

Beyond the preview

Go deeper on Yunyi Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yunyi Pharmaceutical.

Explore the full profile